Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Tick-Borne Relapsing Fever. Data from NIH RePORTER, last 36 months.
Tick-Borne Relapsing Fever has active NIH research funding with 11 funded grants totaling $6.3M.
4 new grants started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Tick-Borne Relapsing Fever. Strongest funded area: Basic Science.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for tick-borne relapsing fever. Trials may be industry-sponsored or funded through non-NIH sources.